Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk

BACKGROUND: Taiwan has the highest renal disease incidence and prevalence in the world. We evaluated the association of statin and renin–angiotensin system inhibitor (RASI) use with dialysis risk in hypertensive patients. METHODS: Of 248,797 patients who received a hypertension diagnosis in Taiwan d...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ju-Chi, Hsu, Yi-Ping, Wu, Szu-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025231/
https://www.ncbi.nlm.nih.gov/pubmed/27632175
http://dx.doi.org/10.1371/journal.pone.0162588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025231/
https://www.ncbi.nlm.nih.gov/pubmed/27632175
http://dx.doi.org/10.1371/journal.pone.0162588

Ejemplares similares